← Leaderboards
Lubov T Timchenko
Cincinnati Childrens Hosp Med Ctr
$11,839,777
Attributed
$11,839,777
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $893.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,839,777 · 8
By mechanism
R01$10,893,712 · 5
R21$792,565 · 2
R03$153,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Myoblasts”
- Charles P Emerson · University Of Pennsylvania$14,063,173
- Elizabeth Hui Chen · Johns Hopkins University$12,621,076
- Robert S. Krauss · Mount Sinai School Of Medicine Of Nyu$9,823,254
- Bradley B Olwin · University Of Colorado At Boulder$9,699,826
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$9,443,164
- Michael Kyba · Ut Southwestern Medical Center$9,104,470
Research focus
MyoblastsMyotonic DystrophyComplexPathologyMutantGenesMolecularPathway InteractionsAffectMouse ModelMessenger RnaMuscleRna-Binding ProteinsProteinsBaseTranslationsChromosomesRna SplicingPhenotypeUntranslated RegionsMyopathyCyclin D3RegulationGenetic Translation
Grant awards (43)
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities$345,944
R01 · FY2024 · NS · contact PI
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities$355,581
R01 · FY2023 · NS · contact PI
GSK3 beta study in patients with Myotonic Dystrophy 1$201,960
R01 · FY2023 · AR · contact PI
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities$361,127
R01 · FY2022 · NS · contact PI
GSK3 beta study in patients with Myotonic Dystrophy 1$296,956
R01 · FY2022 · AR · contact PI
GSK3 beta study in patients with Myotonic Dystrophy 1$418,000
R01 · FY2021 · AR · contact PI
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities$359,491
R01 · FY2021 · NS · contact PI
GSK3 beta study in patients with Myotonic Dystrophy 1$446,321
R01 · FY2020 · AR · contact PI
CNS in congenital DM1: pathogenesis and therapeutic opportunities$358,917
R01 · FY2020 · NS · contact PI
GSK3 beta study in patients with Myotonic Dystrophy 1$447,079
R01 · FY2019 · AR · contact PI
Myotonic Dystrophy type 2$350,624
R01 · FY2015 · AR · contact PI
Inhibition of GSK3 beta as potential therapy for DM1$198,806
R21 · FY2015 · AR · contact PI
Myotonic Dystrophy type 2$343,612
R01 · FY2014 · AR · contact PI
Inhibition of GSK3 beta as potential therapy for DM1$171,600
R21 · FY2014 · AR · contact PI
Myotonic Dystrophy type 2$333,091
R01 · FY2013 · AR · contact PI
The toxicity of the RNA CGG repeats in FXTAS$135,466
R21 · FY2013 · NS · contact PI
The toxicity of the RNA CGG repeats in FXTAS$91,068
R21 · FY2013 · NS · contact PI
Myotonic Dystrophy type 2$350,623
R01 · FY2012 · AR · contact PI
Molecular mechanisms of Myotonic Dystrophy 1$331,390
R01 · FY2012 · AR · contact PI
The toxicity of the RNA CGG repeats in FXTAS$195,625
R21 · FY2012 · NS · contact PI
Molecular mechanisms of Myotonic Dystrophy 1$15,650
R01 · FY2012 · AR · contact PI
Myotonic Dystrophy type 2$350,623
R01 · FY2011 · AR · contact PI
Molecular Mechanisms of Myotonic Dystrophy$307,000
R01 · FY2010 · AR · contact PI
Molecular Mechanisms of Myotonic Dystrophy$307,000
R01 · FY2009 · AR · contact PI
Myotonic Dystrophy Type 2$284,220
R01 · FY2009 · AR · contact PI
Mechanisms of decay of toxic CUGn RNA in DM1 patients$76,750
R03 · FY2009 · NS · contact PI
Myotonic Dystrophy Type 2$275,978
R01 · FY2008 · AR · contact PI
Mechanisms of decay of toxic CUGn RNA in DM1 patients$76,750
R03 · FY2008 · NS · contact PI
Myotonic Dystrophy Type 2$281,610
R01 · FY2007 · AR · contact PI
The Role of RNA-Binding Proteins in Myogenesis$246,874
R01 · FY2007 · AR · contact PI
Myotonic Dystrophy Type 2$290,021
R01 · FY2006 · AR · contact PI
Molecular Mechanisms of Myotonic Dystrophy$263,065
R01 · FY2006 · AR · contact PI
The Role of RNA-Binding Proteins in Myogenesis$254,247
R01 · FY2006 · AR · contact PI
The Role of RNA-Binding Proteins in Myogenesis$282,940
R01 · FY2005 · AR
Myotonic Dystrophy Type 2$282,167
R01 · FY2005 · AR
Molecular Mechanisms of Myotonic Dystrophy$269,395
R01 · FY2005 · AR
The Role of RNA-Binding Proteins in Myogenesis$282,940
R01 · FY2004 · AR
Molecular Mechanisms of Myotonic Dystrophy$282,940
R01 · FY2004 · AR
Molecular Mechanisms of Myotonic Dystrophy$282,940
R01 · FY2003 · AR
RNA-Binding Proteins in Myogenesis$282,940
R01 · FY2003 · AR
Molecular Mechanisms of Myotonic Dystrophy$282,940
R01 · FY2002 · AR
MOLECULAR MECHANISMS OF MYOTONIC DYSTROPHY$237,208
R01 · FY2001 · AR
MOLECULAR MECHANISMS OF MYOTONIC DYSTROPHY$230,298
R01 · FY2000 · AR